pRCC vs. ccRCC is specifically characterized by MET mutations and gains of chromosomes 7,12,16 and 17 as possible drivers [11, 12] whereas losses of heterozygosity of chromosome 3p and inactivating mutations of the VHL gene characterize ccRCC [13]. Here, VHL is linked to nonpapillary renal cell carcinoma.